Evidence map›Paper›PMID 40496546›Full record

ArticleOncology letters2025

Chromophobe renal cell carcinoma with sarcomatoid change: A case report.

Ae Ri Ahn, Sang Jae Noh, Young Bum Jeong, Kyoung Min Kim

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ae Ri AhnDepartment of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Research Institute for Endocrine Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk-do 54907, Republic of Korea.
Sang Jae NohDepartment of Forensic Medicine, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Research Institute for Endocrine Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk-do 54907, Republic of Korea.
Young Bum JeongDepartment of Urology, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Research Institute for Endocrine Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk-do 54907, Republic of Korea.
Kyoung Min KimDepartment of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Research Institute for Endocrine Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk-do 54907, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromophobe renal cell carcinoma (ChRCC) is a rare type of kidney cancer that is generally associated with a favorable prognosis. By contrast, RCC with sarcomatoid transformation exhibits a more aggressive clinical course, with its pathogenesis remaining largely unclear. The present study reports a case of ChRCC with sarcomatoid changes. A 54-year-old woman presented to the Department of Urology for evaluation of an incidentally detected left renal mass. Histological examination of the resected tumor revealed two distinct components: One with conventional ChRCC morphology and the other comprising highly pleomorphic, poorly differentiated cells. Next-generation sequencing of the two components revealed chromosomal losses in multiple chromosomes and variations in the

Indexed as

chromophobe renal cell carcinomakidneynext-generation sequencingsarcomatoid renal cell carcinoma

Identifiers

PMID40496546
PMCPMC12150012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.